News for Gilead Sciences, Inc. (GILD.MX)

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Friday. Shares of Skechers U.S.A., Inc. SKX fell sharply in to...

Shares of Coursera, Inc. COUR rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Cours...

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Philli...

Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2025 Earnings Conference Call April 24, 2025 4:30 PM ETCompany ParticipantsJacquie Ross - SVP, Treasury &...

In the current market session, Gilead Sciences Inc. GILD share price is at $107.00, after a 1.41% increase. Moreover, over the past month, the stock decreased b...

Key Takeaways: Gilead Sciences (GILD) is scheduled to release its Q1 earnings on April 24th. Analysts predict an EPS of $1.74 and revenue of $6.78 billio

We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other cheap NASDAQ stocks. On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an […]

We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc.

Gilead Sciences (GILD) reports successful Phase 3 trial results for Trodelvy® plus Keytruda® in metastatic triple-negative breast cancer. The combinat

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025

**media[597931]**

We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a look at where Gilead Sciences Inc. (NASDAQ:GILD) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined ‘The Exchange’ on […]

Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

**media[592903]**

Exploring the Strategic Moves of Parnassus Value Equity Fund (Trades, Portfolio) in Q1 2025 Parnassus Value Equity Fund (Trades, Portfolio) recently submitted

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.

Summary Gilead Sciences Inc (GILD), a leading biopharmaceutical company, has announced that it will release its first quarter 2025 financial results on Thursday

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24, 2025 af

Gilead Sciences (GILD) to announce its Q1 2025 financial results on April 24, 2025, post-market close. A live webcast discussing the results will be hel